These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

396 related items for PubMed ID: 15816610

  • 1. Circulating hormone levels in breast cancer patients. correlation with serum tumor markers and the clinical and biological features of the tumors.
    Hernández L, Nuñez-Villarl MJ, Martínez-Arribas F, Pollán M, Schneider J.
    Anticancer Res; 2005; 25(1B):451-4. PubMed ID: 15816610
    [Abstract] [Full Text] [Related]

  • 2. Circulating estradiol defines the tumor phenotype in menopausal breast cancer patients.
    Schneider J, Martín-Gutiérrez S, Tresguerres JA, García-Velasco JA.
    Maturitas; 2009 Sep 20; 64(1):43-5. PubMed ID: 19647960
    [Abstract] [Full Text] [Related]

  • 3. Immunofluorometric study of Bcl-2 and Bax expression in clinical fresh tumor samples from breast cancer patients.
    Martínez-Arribas F, Núñez-Villar MJ, Lucas AR, Sánchez J, Tejerina A, Schneider J.
    Anticancer Res; 2003 Sep 20; 23(1B):565-8. PubMed ID: 12680147
    [Abstract] [Full Text] [Related]

  • 4. Peptide and steroid hormone levels in pre- and postmenopausal breast carcinoma.
    Bhatavdekar JM, Shah NG, Trivedi SN, Karelia NH.
    Neoplasma; 1987 Sep 20; 34(1):95-9. PubMed ID: 3104809
    [Abstract] [Full Text] [Related]

  • 5. Prospective evaluation of tumor markers (c-erbB-2 oncoprotein, CEA and CA 15.3) in patients with locoregional breast cancer.
    Molina R, Filella X, Zanon G, Pahisa J, Alicarte J, Munoz M, Farrus B, Ballesta AM.
    Anticancer Res; 2003 Sep 20; 23(2A):1043-50. PubMed ID: 12820345
    [Abstract] [Full Text] [Related]

  • 6. Relationships between circulating hormone levels, mammographic percent density and breast cancer risk factors in postmenopausal women.
    Johansson H, Gandini S, Bonanni B, Mariette F, Guerrieri-Gonzaga A, Serrano D, Cassano E, Ramazzotto F, Baglietto L, Sandri MT, Decensi A.
    Breast Cancer Res Treat; 2008 Mar 20; 108(1):57-67. PubMed ID: 17468953
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Changing estrogen and progesterone receptor patterns in breast carcinoma during the menstrual cycle and menopause.
    Pujol P, Daures JP, Thezenas S, Guilleux F, Rouanet P, Grenier J.
    Cancer; 1998 Aug 15; 83(4):698-705. PubMed ID: 9708933
    [Abstract] [Full Text] [Related]

  • 9. Proliferation measurement in breast cancer by two different methods.
    Martínez-Arribas F, Martín-Garabato E, Lafuente P, Tejerina A, Lucas R, Sánchez J, Schneider J.
    Anticancer Res; 2006 Aug 15; 26(1A):199-202. PubMed ID: 16475699
    [Abstract] [Full Text] [Related]

  • 10. A prospective prognostic study of the hormonal milieu at the time of surgery in premenopausal breast carcinoma.
    Pujol P, Daures JP, Brouillet JP, Chang S, Rouanet P, Bringer J, Grenier J, Maudelonde T.
    Cancer; 2001 May 15; 91(10):1854-61. PubMed ID: 11346866
    [Abstract] [Full Text] [Related]

  • 11. Serum tumour markers CEA, AFP, CA 15-3, TPS and Neu in diagnosis of breast cancer.
    Eskelinen M, Kataja V, Hämäläinen E, Kosma VM, Penttilä I, Alhava E.
    Anticancer Res; 1997 May 15; 17(2B):1231-4. PubMed ID: 9137478
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Differences in Ki67 and c-erbB2 expression between screen-detected and true interval breast cancers.
    Crosier M, Scott D, Wilson RG, Griffiths CD, May FE, Westley BR.
    Clin Cancer Res; 1999 Oct 15; 5(10):2682-8. PubMed ID: 10537329
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
    Eliassen AH, Missmer SA, Tworoger SS, Spiegelman D, Barbieri RL, Dowsett M, Hankinson SE.
    J Natl Cancer Inst; 2006 Oct 04; 98(19):1406-15. PubMed ID: 17018787
    [Abstract] [Full Text] [Related]

  • 19. [Steroid receptor levels in human breast carcinomas in relation to serum hormone levels in postmenopausal patients (author's transl)].
    Reiner G, Bieglmayer C, Jakesz R, Kees A, Kolb R, Spona J.
    Wien Klin Wochenschr; 1981 May 29; 93(11):339-42. PubMed ID: 6791390
    [Abstract] [Full Text] [Related]

  • 20. Preoperative serum levels of follicle stimulating hormone (FSH) and prognosis in invasive breast cancer.
    Eskelinen M, Nordén T, Lindgren A, Wide L, Adami HO, Holmberg L.
    Eur J Surg Oncol; 2004 Jun 29; 30(5):495-500. PubMed ID: 15135476
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.